• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.

作者信息

Tsubo T, Hashimoto Y, Araki I, Ishihara H, Matsuki A

机构信息

Intensive care Unit, University of Hirosaki, School of Medicine, Aomori-ken, Japan.

出版信息

Intensive Care Med. 1996 Nov;22(11):1176-8. doi: 10.1007/BF01709332.

DOI:10.1007/BF01709332
PMID:9120109
Abstract

OBJECTIVE

To assess the influence of continuous hemodiafiltration (CHDF) on cortisol and catecholamine kinetics in multiple organ dysfunction syndrome.

DESIGN

Consecutive clinical study.

SETTING

General intensive care unit of a university hospital.

PATIENTS

Ten adult patients with multiple organ dysfunction syndrome requiring CHDF.

MEASUREMENTS AND RESULTS

A total of 40 samples were collected during CHDF for cortisol and catecholamine assays. The clearances for cortisol, epinephrine, norepinephrine and dopamine were 2.5 +/- 1.7 ml/min, 26.3 +/- 2.7 ml/min, 16.7 +/- 4.2 ml/min and 26.3 +/- 2.6 ml/min (Mean +/_ SE), and their daily extractions were 1.8 +/- 0.2 mg/day, 11.4 +/- 4.8 micrograms/day, 1.0 +/- 0.1 micrograms and 2.3 +/- 0.3 micrograms/day, respectively. There were no significant changes in blood cortisol and catecholamine levels during CHDF conducted for 48 h.

CONCLUSIONS

The cortisol and catecholamine losses during CHDF were small and unlikely to lead to hemodynamic disturbances.

摘要

相似文献

1
Cortisol and catecholamine kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.
Intensive Care Med. 1996 Nov;22(11):1176-8. doi: 10.1007/BF01709332.
2
Ketamine and midazolam kinetics during continuous hemodiafiltration in patients with multiple organ dysfunction syndrome.多器官功能障碍综合征患者持续血液透析滤过期间氯胺酮和咪达唑仑的药代动力学
Intensive Care Med. 2001 Jun;27(6):1087-90. doi: 10.1007/s001340100965.
3
Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.连续性静脉-静脉血液滤过联合透析对急性肾衰竭危重症患者激素及儿茶酚胺清除率的影响
Crit Care Med. 1994 May;22(5):833-7. doi: 10.1097/00003246-199405000-00020.
4
The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF).高细胞因子血症在肿瘤溶解综合征(TLS)病理生理学中的作用以及使用聚甲基丙烯酸甲酯膜血液滤过器(PMMA-CHDF)进行持续血液透析滤过治疗。
Transfus Apher Sci. 2009 Feb;40(1):41-7. doi: 10.1016/j.transci.2008.11.004. Epub 2008 Dec 23.
5
Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization. Modulation by continuous sedation. Multicenter Study of Perioperative Ischemia (McSPI) Research Group, and the Ischemia Research and Education Foundation (IREF).心肌血运重建术后尿和血浆儿茶酚胺及皮质醇浓度。持续镇静的调节作用。围手术期缺血多中心研究(McSPI)研究组及缺血研究与教育基金会(IREF)。
Anesthesiology. 1997 Apr;86(4):785-96. doi: 10.1097/00000542-199704000-00008.
6
Pharmacokinetics of nafamostat mesilate during continuous hemodiafiltration with a polyacrylonitrile membrane.甲磺酸萘莫司他在使用聚丙烯腈膜进行连续性血液透析滤过期间的药代动力学
Ther Apher Dial. 2003 Oct;7(5):483-5. doi: 10.1046/j.1526-0968.2003.00088.x.
7
In vivo catecholamine extraction during continuous hemodiafiltration in inotrope-dependent patients.在依赖血管活性药物的患者进行持续血液透析滤过期间的体内儿茶酚胺提取。
ASAIO Trans. 1991 Jul-Sep;37(3):M324-5.
8
[Kinetic modeling during continuous hemodiafiltration in patients with sepsis and multiorgan failure].[脓毒症和多器官功能衰竭患者持续血液透析滤过期间的动力学建模]
Anesteziol Reanimatol. 2002 Nov-Dec(6):52-5.
9
Improved outcome prediction for patients with multiple organ failure undergoing continuous hemodiafiltration.对接受持续性血液透析滤过的多器官功能衰竭患者的预后预测得到改善。
Ther Apher. 2001 Feb;5(1):31-5. doi: 10.1046/j.1526-0968.2001.005001031.x.
10
Continuous venovenous hemodiafiltration in patients with multiple organ dysfunction syndrome in an intensive care unit.连续性静脉-静脉血液透析滤过在重症监护病房多器官功能障碍综合征患者中的应用。
MEDICC Rev. 2012 Jul;14(3):26-30. doi: 10.37757/MR2012V14.N3.5.

引用本文的文献

1
Adrenal function testing in dialysis patients - a review of the literature.透析患者的肾上腺功能检测——文献综述。
BMC Nephrol. 2021 Nov 1;22(1):360. doi: 10.1186/s12882-021-02541-5.

本文引用的文献

1
The determination of plasma free hydrocortisone and corticosterone by a combined fluorimetric and modified Porter-Silber procedure.采用荧光法与改良波特-西尔伯法联合测定血浆游离氢化可的松和皮质酮。
Clin Chim Acta. 1961 Sep;6:686-95. doi: 10.1016/0009-8981(61)90115-2.
2
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.持续静脉-静脉血液滤过联合透析可清除脓毒症患者循环中的细胞因子。
Crit Care Med. 1993 Apr;21(4):522-6. doi: 10.1097/00003246-199304000-00011.
3
[The simultaneous determination of plasma concentrations of norepinephrine, epinephrine and dopamine by gas chromatography-mass spectrometry].
[气相色谱-质谱联用法同时测定血浆中去甲肾上腺素、肾上腺素和多巴胺的浓度]
Masui. 1984 Oct;33(10):1099-103.
4
[Effect of hemodialysis on pituitary-adrenal function].[血液透析对垂体-肾上腺功能的影响]
Nihon Jinzo Gakkai Shi. 1982 Mar;24(3):235-52.
5
Prognosis in acute organ-system failure.急性器官系统衰竭的预后。
Ann Surg. 1985 Dec;202(6):685-93. doi: 10.1097/00000658-198512000-00004.
6
Variable adrenocortical function in acute medical illness.
Crit Care Med. 1985 Jun;13(6):477-9. doi: 10.1097/00003246-198506000-00007.
7
High output circulatory failure in acute adrenal insufficiency.
Crit Care Med. 1988 Mar;16(3):296-7. doi: 10.1097/00003246-198803000-00019.
8
Vasoactive hormones during hemodialysis with intermittent ultrafiltration.
ASAIO Trans. 1990 Jul-Sep;36(3):M367-9.
9
Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure.持续血液滤过和血液透析滤过在多器官功能衰竭治疗中的应用
Contrib Nephrol. 1991;93:42-6. doi: 10.1159/000420183.
10
Acute renal failure associated with multiple organ failure: pump-assisted continuous venovenous hemofiltration, the ultimate treatment modality.
Contrib Nephrol. 1991;93:32-8. doi: 10.1159/000420181.